- Home
- MRKR vs SEGG Comparison
MRKR vs SEGG Comparison
Compare MRKR & SEGG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRKR | SEGG |
|---|---|---|
| Founded | 1999 | 2015 |
| Country | United States | United States |
| Employees | N/A | 12 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2M | 19.9M |
| IPO Year | 2010 | 2023 |
Fundamental Metrics
Financial Performance| Metric | MRKR | SEGG |
|---|---|---|
| Price | $1.35 | $1.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $10.00 | ★ $20.00 |
| AVG Volume (30 Days) | 60.6K | ★ 1.7M |
| Earning Date | 05-14-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.61 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $936.27 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.81 | $0.46 |
| 52 Week High | $4.07 | $7.61 |
Technical Indicators
Market Signals| Indicator | MRKR | SEGG |
|---|---|---|
| Relative Strength Index (RSI) | 40.19 | 41.24 |
| Support Level | $0.84 | $0.97 |
| Resistance Level | $1.40 | $1.66 |
| Average True Range (ATR) | 0.06 | 0.28 |
| MACD | -0.01 | -0.09 |
| Stochastic Oscillator | 3.85 | 12.88 |
Price Performance
Historical ComparisonAbout MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).
About SEGG Lottery.com Inc.
Sports Entertainment Gaming Global Corp is a sports, entertainment and gaming group operating digital assets such as Sports.com and Lottery.com. It is focused on immersive fan engagement, ethical gaming and AI-driven live experiences.